Consensus and controversy of liquid biopsy using circulating tumour DNA (ctDNA) for molecular residual disease detection in colorectal cancer. // The Lancet Regional Health - Western Pacific. – URL: https://www.sciencedirect.com/science/article/pii/S2666606526002051?dgcid=rss_sd_all
Consensus and controversy of liquid biopsy using circulating tumour DNA (ctDNA) for molecular residual disease detection in colorectal cancer. The Lancet Regional Health - Western Pacific. https://www.sciencedirect.com/science/article/pii/S2666606526002051?dgcid=rss_sd_all
“Consensus and controversy of liquid biopsy using circulating tumour DNA (ctDNA) for molecular residual disease detection in colorectal cancer.” The Lancet Regional Health - Western Pacific.
@article{article69219,
title = {Consensus and controversy of liquid biopsy using circulating tumour DNA (ctDNA) for molecular residual disease detection in colorectal cancer},
journal = {The Lancet Regional Health - Western Pacific},
url = {https://www.sciencedirect.com/science/article/pii/S2666606526002051?dgcid=rss_sd_all}
}
ABSTRACT Aim To investigate the longitudinal association between early‐life movement behaviour patterns and later clinically diagnosed obesity. Method In the population‐based All Babies in Southeast Sweden (ABIS) cohort, 16 415 children...